Resources

Publications

Publications

This joint paper published by scientists at Repare Therapeutics, BioAgilytix and Hypha Discovery is the first report of a N-glucuronide metabolite of camonsertib formed in human hepatocyte incubations. The structure of the metabolite was elucidated by NMR after scale-up using microbial biotransformation to produce the N-glucuronide.

It’s now been shown that metabolites of ivermectin contribute to its anti-parasitic activity. This paper describes the first time the mosquito-lethal effect of ivermectin metabolites on Anopheles survival has been investigated in an in vitro system. Hypha made the elusive O-demethylated metabolites needed for this study.

In this paper, authors from Hypha and Incyte Corporation discuss the impact and application of biotransformation of drugs by mammalian systems, microorganisms, and recombinant enzymes, covering active and reactive metabolites, the impact of the gut microbiome on metabolism, and how insights gained from biotransformation studies can influence drug design.

In Chapter 4 of the book on “Identification and quantification of drugs, metabolites, drug metabolizing enzymes and transporters”, Hypha authors summarise the different methods employed for producing metabolites of drugs, illustrated with representative examples from the literature and work undertaken at Hypha. The chapter also includes a discussion and examples of the use of NMR spectroscopy for structure elucidation of metabolites.

Ready to begin? Our scientists are available to talk through your requirements

Contact Us 2

Subscribe to our newsletter and blog!

Newsletter Signup
Which do you wish to signup for?

Don't forget to subscribe to our newsletter and blog!

Newsletter Signup
Which do you wish to signup for?